Dynepo - treatment of anaemia

Dynepo (epoetin delta), indicated for the treatment of anaemia associated with chronic renal failure in patients on dialysis and non-dialysed patients, has been launched by Shire Pharmaceuticals.

Further information: Shire 01256 894000

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in